4CAMPBELL I W. The role of mefformin and pioglitazone in early combination treatment of type 2 diabetes mellitus[J]. British Journal of Diabetes &Vascular Disease, 2006,6 (5) : 207.
5DESILETS A R. Role of Mefformin for weight management inpatients without type 2 diabetes[J]. The Annals of Pharmacotherapy, 2008,42 (6) : 817.
6DE VOGLI R, FERRIE J E, CHANDOLA T, et al. Unfairness and health: evidence from the Whitehall II Study[J].J Epidemiol Community Health, 2007,61 : 513.
7CARIN ALM-ROIJER, MARTIN S, GIGGI U, et al. Better knowledge improve adherence to lifestyle changes and medication in patients with coronary heart disease[JJ. European Society of Cardiology,2004, (3) :321.
8DOMANSKI M, MITCHELL G, PFEFFER M, et al. Pulse pressure and cardiovascular disease related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) [J]. JAMA, 2002,287(20) :2677.
9FRANKLIN S S, LARSON M G, KHAN S A, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study[J]. Circulation, 2001,103 : 1245.
10ALMGREN T, PERSSON B, WILHELMSEN L, et al. Stroke and coronary heart disease in treated hypertension:a prospective cohort study[J]. J IntemMed, 2005,257 (6) : 496.
